Lv34
264 积分 2025-09-03 加入
Datopotamab Deruxtecan: First Approval
10天前
已完结
Antibody–drug conjugates in cancer therapy: current landscape, challenges, and future directions
14天前
已完结
Tecotabart vedotin in Claudin 18.2-positive advanced gastric/gastroesophageal junction cancer: A Bayesian phase 1/2 clinical trial
14天前
已完结
Datopotamab Deruxtecan, a Novel TROP2-directed Antibody-drug Conjugate, Demonstrates Potent Antitumor Activity by Efficient Drug Delivery to Tumor Cells
20天前
已完结
A novel inhalable nanobody targeting IL-4Rα for the treatment of asthma
20天前
已完结
Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers: an emerging paradigm
22天前
已完结
Datopotamab Deruxtecan, a Novel TROP2-directed Antibody–drug Conjugate, Demonstrates Potent Antitumor Activity by Efficient Drug Delivery to Tumor Cells
24天前
已完结
Receptor-ubiquitination-targeting antibody-drug conjugates for enhanced endocytosis and lysosomal delivery
1个月前
已完结
Next generation miRNA inhibition using short anti-seed PNAs encapsulated in PLGA nanoparticles
1个月前
已完结
Inhibition of Burkitt's lymphoma cells growth in SCID mice by a PNA specific for a regulatory sequence of the translocated c-myc
1个月前
已完结
皖公网安备34019202002308
